DK0406398T3 - Præparater og metode til behandlingen eller profylaksen af sepsis eller septisk chok - Google Patents

Præparater og metode til behandlingen eller profylaksen af sepsis eller septisk chok

Info

Publication number
DK0406398T3
DK0406398T3 DK90902432.5T DK90902432T DK0406398T3 DK 0406398 T3 DK0406398 T3 DK 0406398T3 DK 90902432 T DK90902432 T DK 90902432T DK 0406398 T3 DK0406398 T3 DK 0406398T3
Authority
DK
Denmark
Prior art keywords
sepsis
prophylaxis
preparations
treatment
septic shock
Prior art date
Application number
DK90902432.5T
Other languages
Danish (da)
English (en)
Inventor
Joyce E Lawrence
Melaine Alpern
Michael J Griffith
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23160797&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0406398(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Int filed Critical Baxter Int
Application granted granted Critical
Publication of DK0406398T3 publication Critical patent/DK0406398T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK90902432.5T 1989-01-24 1990-01-17 Præparater og metode til behandlingen eller profylaksen af sepsis eller septisk chok DK0406398T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/300,836 US5093117A (en) 1989-01-24 1989-01-24 Compositions and method for the treatment or prophylaxis of sepsis or septic shock

Publications (1)

Publication Number Publication Date
DK0406398T3 true DK0406398T3 (da) 1995-07-17

Family

ID=23160797

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90902432.5T DK0406398T3 (da) 1989-01-24 1990-01-17 Præparater og metode til behandlingen eller profylaksen af sepsis eller septisk chok

Country Status (8)

Country Link
US (1) US5093117A (ja)
EP (1) EP0406398B1 (ja)
JP (1) JP3038006B2 (ja)
CA (1) CA1339990C (ja)
DE (1) DE69019072T2 (ja)
DK (1) DK0406398T3 (ja)
ES (1) ES2074563T3 (ja)
WO (1) WO1990008556A1 (ja)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571786A (en) * 1990-08-16 1996-11-05 Immuno Aktiengesellschaft Use of protein C or the activation peptide of protein C for preparing a pharmaceutical preparation
AT402260B (de) * 1990-08-16 1997-03-25 Immuno Ag Protein c-hältige pharmazeutische präparation
AT397615B (de) * 1991-05-14 1994-05-25 Immuno Ag Arzneimittel enthaltend protein c
AU4784693A (en) 1992-07-24 1994-02-14 Oklahoma Medical Research Foundation Blockade of protein c activation reduces microvascular surgical blood loss
EP0728210B1 (en) * 1993-11-12 2005-04-13 Gilead Sciences, Inc. Thrombin mutants
US7060484B1 (en) 1993-11-12 2006-06-13 Gilead Sciences, Inc. Polypeptides and coagulation therapy
US5580856A (en) * 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof
US20060127387A1 (en) * 1997-04-22 2006-06-15 Zikria Bashir A Compositions based on polysaccharides and protein C and methods of using the same for preventing and treating sepsis and other conditions
ID22933A (id) * 1997-04-28 1999-12-16 Lilly Co Eli Fomulasi protien c terakivasi
US6630137B1 (en) 1997-04-28 2003-10-07 Eli Lilly And Company Activated protein C formulations
DE19726248C2 (de) * 1997-06-20 2000-03-02 Mucos Pharma Gmbh & Co Verwendung proteolytischer Enzyme und Rutosid zur Behandlung von septischem Schock
US6953568B1 (en) 1998-08-25 2005-10-11 Oklahoma Medical Research Foundation Targeting of molecules to large vessel endothelium using EPCR
IL142248A0 (en) * 1998-10-22 2002-03-10 Lilly Co Eli Methods for treating sepsis
WO2000037022A2 (en) * 1998-12-21 2000-06-29 Eli Lilly And Company Combination therapy for the treatment of sepsis
US6679870B1 (en) 1999-07-23 2004-01-20 Vasca, Inc. Methods and kits for locking and disinfecting implanted catheters
US6685694B2 (en) 1999-07-23 2004-02-03 Vasca, Inc. Methods and kits for locking and disinfecting implanted catheters
US20030158111A1 (en) * 1999-10-01 2003-08-21 David Bar-Or Methods and products for oral care
US7592304B2 (en) * 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US7632803B2 (en) 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US7204981B2 (en) * 2000-03-28 2007-04-17 Eli Lilly And Company Methods of treating diseases with activated protein C
US7087578B2 (en) 2000-05-24 2006-08-08 Eli Lilly And Company Formulations and methods for treating hypercoagulable states
US20030190314A1 (en) * 2001-01-30 2003-10-09 The Lauridsen Group Methods and compositions of treatment for modulating the immune system of animals
US20040202660A1 (en) * 2001-01-30 2004-10-14 Joy Campbell Methods and compositions for treatment of immune dysfunction disorders
EP1357943A2 (en) * 2001-01-30 2003-11-05 The Lauridsen Group Incorporated Methods and compositions for modulating the immune system of animals
JP2004535461A (ja) * 2001-07-19 2004-11-25 ディーエムアイ バイオサイエンシズ インコーポレイテッド プロテインｃの不活性化を抑制するための銅キレート剤の使用
WO2003075834A2 (en) * 2002-03-08 2003-09-18 Eli Lilly And Company Activated protein c formulations
CA2524534C (en) 2003-05-15 2012-12-11 Sek Chung Fung Methods and compositions for the prevention and treatment of sepsis
AU2005313971B2 (en) * 2004-12-08 2011-10-13 Immunomedics, Inc. Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer
US8834862B2 (en) * 2005-04-19 2014-09-16 Nanocyte Inc. Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
ITFI20070063A1 (it) * 2007-03-15 2008-09-16 Kedrion Spa Concentrato di proteina c contenente proteina s, sua preparazione ed uso.
EP2869833B1 (en) 2012-07-04 2018-04-04 ZZ Biotech LLC. Activated protein c for use in the treatment of inflammatory skin disorders
WO2015157791A1 (en) 2014-04-16 2015-10-22 The University Of Sydney Treatment of abnormal cutaneous scarring

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4587121A (en) * 1983-06-14 1986-05-06 Miles Laboratories, Inc. High titer Pseudomonas immune serum globulin
GB8319538D0 (en) * 1983-07-20 1983-08-24 Beecham Group Plc Compounds
US5179018A (en) * 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
DE3516119A1 (de) * 1985-05-04 1986-11-06 Biotest Pharma GmbH, 6000 Frankfurt Polyvalentes hyperimmunglobulin-praeparat
US5258288A (en) * 1986-07-25 1993-11-02 Genzyme Corporation Vector containing DNA encoding mature human protein S

Also Published As

Publication number Publication date
JP3038006B2 (ja) 2000-05-08
EP0406398A1 (en) 1991-01-09
ES2074563T3 (es) 1995-09-16
US5093117A (en) 1992-03-03
CA1339990C (en) 1998-08-11
JPH03503536A (ja) 1991-08-08
DE69019072D1 (de) 1995-06-08
DE69019072T2 (de) 1995-11-30
EP0406398A4 (en) 1991-07-03
WO1990008556A1 (en) 1990-08-09
EP0406398B1 (en) 1995-05-03

Similar Documents

Publication Publication Date Title
DK0406398T3 (da) Præparater og metode til behandlingen eller profylaksen af sepsis eller septisk chok
DK10289A (da) Fremgangsmaade og praeparater til forebyggelse af ulcus
DE69028373D1 (de) Mehrstufiges Verriegelungssystem und -verfahren
DK0445255T3 (da) Behandling af tilstande og sygdom
DK50593D0 (da) System og fremgangsmaade til behandling af biologiske vaesker
DK3695A (da) Fremgangsmåde og anlæg til behandling af biologiske fluider
DK81390A (da) Fremgangsmaade og anordning til transport af genstande
DK472187D0 (da) Fremgangsmaade og anlaeg til transport af stykformede materialer
NO914665L (no) Fremgangsmaate til fjerning av trialkylarsiner og sorpsjonsmateriale for utfoerelse av fremgangsmaaten
DK299989A (da) Fremgangsmaade og anlaeg til fjernelse af asbestholdige materialer
NO901272L (no) Sammensetning og fremgangsmaate for fjerning av sulfider.
DK0594528T3 (da) Fremgangsmåde og anlæg til behandling af halve slagtekroppe
DK80889D0 (da) Badeanlaeg og fremgangsmaade til anvendelse af samme
DK0388620T3 (da) Fremgangsmåde til fremstilling af o-carboxy-pyridyl- og o-carboxyquinolylimidazolinoner
DK145192D0 (da) Fremgangsmaade og anlaeg til behandling af slagtekroppe
DK165475C (da) Fremgangsmaade og anlaeg til behandling eller undersoegelse af slagtekroppe
DK163189A (da) Fremgangsmaade og anlaeg til behandling af slamformigt affald
DK0624573T3 (da) Iodvitamin-D3-forbindelser og fremgangsmåde til fremstilling af samme
DK484688A (da) Fremgangsmaade til behandling af mastitis og andre staphylococcusinfektioner
IT8983344A0 (it) Metodo per il trattamento di liquami e rispettivo impianto.
DK641189D0 (da) Praeparat til behandling af glaucom og fremgangsmaade til fremstilling af et saadant praeparat
NO951033D0 (no) Smeltebearbeidbar blokk-kopolyesterimid og fremgangsmåte for fremstilling derav
DK45289D0 (da) Fremgangsmaade og anlaeg til behandling af maelk
DK674787A (da) Herbicidkomposition og fremgangsmaade til anvendelse af samme
NO900668L (no) Komposisjon og metode for fremstilling av bygningsstener.